English Journal
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease.
- Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ.SourceThe Queen Elizabeth Hospital, Adelaide, Australia. drzusmani@yahoo.co.uk.
- Cochrane database of systematic reviews (Online).Cochrane Database Syst Rev.2011 Nov 9;(11):CD008483.
- BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is characterised by inflammation of the airways and destruction of pulmonary tissue with post bronchodilator FEV1/FVC of <0.70 (forced expiratory volume in one second/forced vital capacity). Evidence indicates an increased prevalence of anx
- PMID 22071851
Japanese Journal
- Effect of 5-{3-[((2S)-1,4-Benzodioxan-2-ylmethyl)amino]propoxy}-1,3-benzodioxole HCl (MKC-242), a Novel 5-HT_<1A>-Receptor Agonist, on Aggressive Behavior and Marble Burying Behavior in Mice
- Abe Michikazu,Nakai Hiroshi,Tabata Reiko [他],SAITO Ken-Ichi,EGAWA Mitsuo
- The Japanese journal of pharmacology 76(3), 297-304, 1998-03
- … These findings indicate that MKC-242 possesses a longer-lasting anxiolytic effect than azapirones. …
- NAID 10008192063
Related Links
- Lou Ann Damsma, LCCE, CD(DONA), CLC, CEIM AZAPIRONES Class of the all you can also search results for gad Azapirone i think, doctor, that includes buspirone andin healthy volunteers Benzodiazepines, antidepressants ...
- www.azapirones.com www.azapirones.com info@azapirones.com
Related Pictures